Hamlet BioPharma AB
Hamlet BioPharma operates in the pharmaceutical industry. The company conducts drug development based on a tumor-killing protein-lipid complex, formed from two natural and harmless molecules found in breast milk. The development aims to produce preparations that will primarily be used for the treatment and prevention of cancer diseases. Hamlet BioPharma was founded in 2015 and is headquartered in Lund.
Quotes for Hamlet BioPharma AB
Board
CEO
- Jakob Testad
Chairperson of the Board
- Catharina Svanborg
Board
- Bill Hansson
- Henrik Sundin
- Magnus Nylen
** Powered by Modular Finance
*Powered by Modular Finance